Skip to content

Seprafilm Adhesion Barrier (chemically modified sodium… recallZ-1647-2008 · Genzyme Corporation · initiated Apr 10, 2008

Terminated All recalls posted in August 2008

Is my device affected?

  1. Compare the model, catalog and lot or serial numbers on your device or its packaging with the code information below. A recall usually covers only specific models or lots.
  2. If yours is listed, follow the instructions from Genzyme Corporation or your healthcare provider. The company's action is summarized under what the company is doing.
  3. Do not stop using a prescribed or implanted device on your own — talk to your healthcare provider first.

Where to find your model and lot numbers · What recall classes and statuses mean

Why it was recalled

Sterility may be compromised

FDA root cause category: Employee error

What the company is doing

Genzyme notified Distributors and hospitals by letter dated 4/10/08, requesting ceasing distribution and return recalled product.

Recall details

Recall number
Z-1647-2008
Recall class
Not yet classified by the FDA
Status
Terminated
Initiated by the company
Apr 10, 2008
Posted by the FDA
Aug 24, 2008
Recalling firm
Genzyme Corporation
Quantity
2632 (10 pack)
FDA submissions
P950034
Distribution
Nationwide Korea, Taiwan, Japan

Product description

Seprafilm Adhesion Barrier (chemically modified sodium hyaluronate/carboxymethylcellulose absorbable adhesion barrier) Product Number: 4301-02

Code information (models, lots, serial numbers)

Lot Numbers:  07NP135 Exp Date: April 2010; 07NP177 Exp Date: May 2010;  07NP199 Exp Date: June 2010;  07NP216 Exp. Date: July 2010;  07NP311 Exp. Date: May 2010

Other devices under the same FDA submission

1 device cleared under P950034 — the recall does not name any of them by identifier. One submission often covers many models, so they may or may not be affected.

Other products in the same recall event

The FDA groups related products into one recall event (event 47758).

Sources and updates

How recalls are matched to devices · Editorial policy · Report an error on this page